Faces of Digital Health

Faces of digital health is a podcast about digital health trends and how healthcare systems around the world adopt technology. The podcast steers away from American centricity in reporting about digital health. I believe this information can be helpful for healthcare entrepreneurs considering different global markets. It can give medical professionals and decision-makers insight into the latest digital health trends.

How Do Nurses See Medication Administration Challenges? (Martina Viduka)

Nurses are the backbone of healthcare. They’re the closest to the patient, they offer support to them and the doctors. Their mission is to make patients feel better and recover as fast as possible. There is a global shortage of nurses and more often than not, nurses are stretched thin. The same as with doctors, mistakes can happen in nursing. You are going to hear from Martina Viduka A practicing nurse and the CEO of Advosense. In this discussion, she presented the nursing perspective on medication management in the hospital setting. This interview was part of the discussions recorded for the movie (OVER)DOSE – How can we prevent medication errors?. Find the link to the movie in the show notes, and see or hear the interviews with other speakers as well. I spoke with 10 experts from six countries across the world to understand why is medication-related patient safety a global problem in which everyone plays a role – the patient and his family, the doctors, the nurses, and the pharmacists.

Watch the documentary (OVER)DOSE – How can we prevent medication errors and the panel discussion on Youtube: https://www.facesofdigitalhealth.com/blog/overdose-how-can-we-prevent-medication-errors

Opportunity: HRSA Announces New Loan Repayment Program for Behavioral Health Providers. Learn more and apply here: https://bhw.hrsa.gov/funding/apply-loan-repayment/star-lrp

How Demanding Is Management of Psychiatric Disorders? (Roni Shiloh)

With mental health being at the forefront of our attention in 2020, next to COVID, have you ever wondered, how the work of a psychiatrist looks like? Many clinicians fear psychiatric drugs, but Roni Shiloh firmly believes the fear is unnecessary. 

Roni Shiloh is an MD, specialized in psychiatry. He headed a closed Psychiatric Department, was Chief Psychiatric Officer at a large Israeli HMO as well a senior lecturer in Tel-Aviv University, Israel. He then worked in the Pharmaceutical industry before starting his own startup Seegnal, which offers clinicians decision support in medication prescribing. The system takes into account many of a patient’s variables to be as accurate as possible, and more importantly, for the decision support to not overwhelm the doctor with alerts. Electronic prescribing and medication management are very complex and plagued with errors, which I tried to outline in the documentary OVERDOSE – How can we prevent medication errors. If you haven’t seen the movie yet, find the link in the show notes, or find the version adapted for radio in one of the previous episodes of this podcast. A few of Roni’s statements from this interview are also in the movie. 

This discussion covers: 

  •  How the work of a psychiatrist looks like, 
  • what are the challenges related to medications in psychiatry,
  • why are decision support systems for medication prescribing currently still mostly frustrating for the users? Various research papers show that 90-96% of alerts get ignored. You’ll be able to hear a little bit more about that in one of the upcoming episodes with the pioneering researcher in the field of the impact of IT on medical professionals – Dr. David W. Bates from Harvard.

Watch the documentary (OVER)DOSE – How can we prevent medication errors and the panel discussion on Youtube: https://www.facesofdigitalhealth.com/blog/overdose-how-can-we-prevent-medication-errors

Opportunity: HRSA Announces New Loan Repayment Program for Behavioral Health Providers. Learn more and apply here: https://bhw.hrsa.gov/funding/apply-loan-repayment/star-lrp

F138 (OVER)DOSE Part 2 – after documentary expert panel discussion

This is a panel discussion that happened after the premiere of the documentary (OVER)DOSE – How can we prevent medication errors? which aired on 29 June. You can listen to the adapted audio-only version of the documentary in episode 137.

The documentary explores and offers an overview of the current challenges and technical solutions related to medication safety to raise awareness about the need to further improve medication-related patient safety. 

Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process.

More than 237 million medication errors are made every year in England, the avoidable consequences of which cost the NHS upwards of £98 million and more than 1700 lives every year, indicate national estimates, published online in the journal BMJ Quality & Safety. 

This panel further highlights issues related to medication safety.

Watch the documentary and the panel on Youtube: https://www.facesofdigitalhealth.com/blog/overdose-how-can-we-prevent-medication-errors

Speakers on the panel:

  • Tjaša Zajc, Author of (OVER)DOSE, Host of Faces of Digital Health
  • Stefan Siekierski, Nurse, Electronic prescribing Project Manager, Better Delivery Manager UK & IE
  • Katrina Azer, Pharmacist, Patient Advocate, Board Member of the Pharmacy Council of New Zealand
  • Robert Johnstone, Board Member of the European Forum for Good Clinical Practice (EFGCP) and International Foundation for Integrated Care (IFIC)
  • Alexander Jankuloski, CEO at Kuwait Hospital
  • Hicham Naim, Global Head Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda
  • Prof. Yu-Chuan Jack-Li – a researcher of artificial intelligence (AI) in medicine and medical informatics, and a practicing dermatologist, the Editor-in-Chief of BMJ Health & Care Informatics

Opportunity: HRSA Announces New Loan Repayment Program for Behavioral Health Providers. Learn more and apply here: https://bhw.hrsa.gov/funding/apply-loan-repayment/star-lrp

F137 (OVER)DOSE Part 1 – documentary adapted for radio

This is a short documentary about medication-related patient safety. The documentary explores and offers an overview of the current challenges and technical solutions related to medication safety to raise awareness about the need to further improve medication-related patient safety. 

Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process.

More than 237 million medication errors are made every year in England, the avoidable consequences of which cost the NHS upwards of £98 million and more than 1700 lives every year, indicate national estimates, published online in the journal BMJ Quality & Safety. 

The documentary premiered on 29 June and was accompanied by an expert panel discussion which you can listen to in episode 138.

Watch the documentary: https://www.facesofdigitalhealth.com/blog/overdose-how-can-we-prevent-medication-errors

Speakers in the movie and this episode:

David W. Bates, Medical Director of Clinical and Quality Analysis, Information Systems, Patient Safety Expert and Harvard MD (Clinical & Research Perspective)

Professor John Horn, PharmD, University of Washington School of Pharmacy, coauthor of “The Top 100 Drug Interactions”; A Guide to Patient Management”

Martina Viduka, Practicing Nurse, Co-Founder of Advosense

David Kliff, author and publisher of the Diabetic Investor eNewsletter, former investment advisor, and as a person living with diabetes (Patient Perspective)

Duncan Cripps, Electronic Prescribing and Medication Management Lead at University Hospitals Plymouth NHS Trust (Pharmacist Perspective)

Roni Shiloh, CEO of Seegnal, MD degree, specialized in Psychiatry (CDS provider and doctor perspective)

Hicham Naim, Global Head Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda (Pharma Perspective)

Marinka Žitnik, Assistant Professor of Biomedical Informatics, Harvard Medical School (Research perspective

Lea Dias, Clinical Pharmacist, Founder and CEO of Quaefacta

Abdulelah Alhawsawi, Ex – founding Director-General of the Saudi Patient Safety Center (SPSC)

Roi Shternin, Founder of the patient-led Israeli society for Dysautonomia (Patient perspective).

Thanks to our Sponsor: Health Resources and Services Administration:

Receive up to $250,000 in student loan repayment in exchange for service in a community disproportionately affected by the opioid crisis. Learn more and apply to join STAR LRP – that stands for the Substance Use Disorder Treatment and Recovery Loan Repayment Program. Applications Close on July 22, 2021

F136 Do You Understand the Psychology of Chronic Disease? (David Kliff, The Diabetic Investor)

David Kliff is the author and publisher of the Diabetic Investor eNewsletter, former investment advisor and as a person living with diabetes. As the author and publisher of the Diabetic Investor eNewsletter, David Kliff has spent the last 20 years analyzing the ups and downs of the diabetes industry. He closely monitors the diabetes biomed, biotech and device market and shares intel on breaking developments in existing and emerging pharmaceutical and tech companies that operate in that space. 

In this episode, David talks about improvements in diabetes care and the psychological impacts and challenges contributing to low adherence to medication adherence and other diabetes treatment-related challenges.

This discussion was recorded as part of the research for the documentary (OVER)DOSE – How can we prevent medication errors? 

Join the premiere on 29 June:

https://www.linkedin.com/events/over-dose-howcanwepreventmedica6800062280823263232/

More details about the event: https://www.facesofdigitalhealth.com/blog/overdose-how-can-we-prevent-medication-errors

Thanks to our Sponsor: Health Resources and Services Administration:

Receive up to $250,000 in student loan repayment in exchange for service in a community disproportionately affected by the opioid crisis. Learn more and apply to join STAR LRP – that stands for the Substance Use Disorder Treatment and Recovery Loan Repayment Program. Applications Close on July 22, 2021

F135 Why is Medication Price Transparency in the US Complicated and Problematic? (Carm Huntress)

Because US healthcare is private and operates by the rules of the free market, prices for services and medications can differ substantially. Solutions such as GoodRx and Amazon Pharmacy are addressing price transparency for consumers. On the other side are the Real Time Prescription Benefit Providers which help physicians see drug prices for a specific patient even before that patient leaves their office. The challenge with knowing how much a drug will cost a patient lies in the fact that different insurance companies have different policies regarding how much they will pay for medication. Patients might have a plan with high deductibles. But it’s not just the provider and the insurance company: prices depend on the Pharmacy Benefit Managers (PMS) – intermediaries that manage prescription drug benefits on behalf of health insurers. PBMs negotiate prices with drug manufacturers and pharmacies. 

In this episode, Carm Huntress, the CEO of RxRevu Real Time Prescription Benefit Provider company, talks about the upcoming challenges of prices related to precision medicine, how drug pricing affects prescribing and treatment, and how price transparency can change the medication prescribing process.

Leave a rating or a review: www.lovethepodcast.com/facesofdigitalhealth

Episode summary: www.facesofdigitalhealth.com/blog/rxrevu-drug-pricing

Watch on Youtube:

Thanks to our Sponsor: Health Resources and Services Administration:

Receive up to $250,000 in student loan repayment in exchange for service in a community disproportionately affected by the opioid crisis. Learn more and apply to join STAR LRP – that stands for the Substance Use Disorder Treatment and Recovery Loan Repayment Program. Applications Close on July 22, 2021

Responses

About Instructor

If you'd like to comment on this course or lecture please Register or Login.

THIS CONTENT IS FOR

Registered Users

Please login or register to continue.